Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

150%

3 of 2 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 1
1(33.3%)
N/A
1(33.3%)
Phase 2
1(33.3%)
3Total
Phase 1(1)
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03130738Phase 2Completed

Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis

Role: collaborator

NCT03450369Phase 1Completed

A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne

Role: collaborator

NCT00737061Not ApplicableTerminated

Safety & Efficacy Study of the Adiana System for Women Who Desire Permanent Birth Control (Sterilization)

Role: collaborator

All 3 trials loaded